Comments: NJ A4052 | 2022-2023 | Regular Session

Bill Title: Establishes three-year sickle cell disease pilot program; appropriates $10,200,000.

Sponsorship: Strong Partisan Bill (Democrat 24-2)

Status: (Passed) 2024-01-08 - Approved P.L.2023, c.242. [A4052 Detail]

Text: Latest bill text (Amended) [HTML]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2022 New Jersey A4052 at this time.

feedback